Brooks O'Neil
Stock Analyst at Lake Street
(0.73)
# 4,038
Out of 5,182 analysts
34
Total ratings
32.35%
Success rate
-19.21%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $3.34 | +199.40% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $4.57 | +75.05% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $19.82 | -39.46% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.56 | +75.44% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.70 | +640.74% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $114.52 | -3.95% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $10.65 | +181.69% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $5.51 | +371.87% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $41.41 | +32.82% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $10.36 | +73.75% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.08 | +120.26% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.39 | +109.21% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $26.00 | - | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $330 | $4.35 | +7,486.21% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $18.46 | +590.68% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.34
Upside: +199.40%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.57
Upside: +75.05%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $19.82
Upside: -39.46%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.56
Upside: +75.44%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.70
Upside: +640.74%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $114.52
Upside: -3.95%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $10.65
Upside: +181.69%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $5.51
Upside: +371.87%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $41.41
Upside: +32.82%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.36
Upside: +73.75%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $9.08
Upside: +120.26%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $26.00
Upside: -
Apr 8, 2022
Initiates: Buy
Price Target: $330
Current: $4.35
Upside: +7,486.21%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $18.46
Upside: +590.68%